Doctor’s Prescription Now Mandatory for High-Alcohol Cough Syrups as Centre Tightens Rules

In a significant move to prevent the misuse of medicines for intoxication, the Central Government has tightened regulations on the sale of certain alcohol-containing medicines, including some cough syrups. The decision is aimed at curbing the growing trend of using medicinal products for recreational intoxication while ensuring they remain available for legitimate medical treatment.

Under the amended provisions of the Drugs Rules, 1945, oral medicines containing more than 12 per cent ethyl alcohol and sold in bottles larger than 30 millilitres can no longer be purchased over the counter. These medicines will now be available only on the prescription of a registered medical practitioner.

To strengthen oversight, the government has placed such medicines under the Schedule H1 category, which is subject to stricter controls compared to many commonly sold pharmaceutical products. Retail chemists will be required to verify a valid prescription before dispensing these medicines to customers.

The new rules also introduce enhanced monitoring requirements for pharmacies. Medical stores must maintain a separate register recording the sale of these formulations, including details of the prescribing doctor, the patient’s prescription and the quantity of medicine dispensed. This will help authorities track the movement of medicines that have a higher risk of misuse.

Officials said the amendments are part of a broader effort to tackle substance abuse and ensure responsible sale of pharmaceutical products. By restricting easy access to high alcohol-content medicinal formulations, the government hopes to reduce their misuse among individuals seeking intoxication rather than medical relief.

The move is expected to improve accountability in the distribution of sensitive medicines and strengthen safeguards against their unauthorized use. At the same time, genuine patients will continue to have access to these medications under proper medical supervision.

Health experts believe the stricter regulations will help strike a balance between ensuring access to essential treatment and preventing the abuse of medicines with a greater potential for misuse.